Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9952359rdf:typepubmed:Citationlld:pubmed
pubmed-article:9952359lifeskim:mentionsumls-concept:C0019682lld:lifeskim
pubmed-article:9952359lifeskim:mentionsumls-concept:C0027361lld:lifeskim
pubmed-article:9952359lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:9952359lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9952359lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:9952359pubmed:issue3lld:pubmed
pubmed-article:9952359pubmed:dateCreated1999-3-30lld:pubmed
pubmed-article:9952359pubmed:abstractTextRepeated exposure to human immunodeficiency virus (HIV) does not always result in seroconversion. Understanding the conditions that permit or protect against progressive infection with HIV is important for vaccine development. Nineteen subjects at risk for HIV infection were CCR-5 genotyped and screened for virus-specific memory cytotoxic T lymphocytes (CTL). None had the Delta32CCR-5/Delta32CCR-5 genotype associated with HIV resistance. HIV-specific CTL were detected in 7 (41.1%) of 17 exposed uninfected subjects versus 0 of 14 seronegative subjects with no HIV risk factors (P=.006, chi2 test). Recognition of virus by CTL in exposed uninfected subjects was major histocompatibility complex class I-restricted and multispecific, and specificity could change with time. Activity could persist up to 34 months after the last virus exposure. The presence of HIV-specific CTL in a greater proportion of seronegative HIV-exposed versus unexposed subjects supports the notion that in some cases, virus exposure induces HIV immunity without seroconversion or disease progression.lld:pubmed
pubmed-article:9952359pubmed:languageenglld:pubmed
pubmed-article:9952359pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9952359pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9952359pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9952359pubmed:statusMEDLINElld:pubmed
pubmed-article:9952359pubmed:monthMarlld:pubmed
pubmed-article:9952359pubmed:issn0022-1899lld:pubmed
pubmed-article:9952359pubmed:authorpubmed-author:LeeJ SJSlld:pubmed
pubmed-article:9952359pubmed:authorpubmed-author:BernardN FNFlld:pubmed
pubmed-article:9952359pubmed:authorpubmed-author:TsoukasC MCMlld:pubmed
pubmed-article:9952359pubmed:authorpubmed-author:YannakisC MCMlld:pubmed
pubmed-article:9952359pubmed:issnTypePrintlld:pubmed
pubmed-article:9952359pubmed:volume179lld:pubmed
pubmed-article:9952359pubmed:ownerNLMlld:pubmed
pubmed-article:9952359pubmed:authorsCompleteYlld:pubmed
pubmed-article:9952359pubmed:pagination538-47lld:pubmed
pubmed-article:9952359pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:meshHeadingpubmed-meshheading:9952359-...lld:pubmed
pubmed-article:9952359pubmed:year1999lld:pubmed
pubmed-article:9952359pubmed:articleTitleHuman immunodeficiency virus (HIV)-specific cytotoxic T lymphocyte activity in HIV-exposed seronegative persons.lld:pubmed
pubmed-article:9952359pubmed:affiliationImmunodeficiency Treatment Center, McGill University Hospital Center, Montreal General Hospital, Montreal, Quebec, H3G 1A4, Canada. mctl@musica.mcgill.calld:pubmed
pubmed-article:9952359pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9952359pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9952359lld:pubmed